Cedazo-Mínguez, A <br/><br/>
Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta.  [electronic resource] 

 -  Journal of neurochemistry  Dec 2003 
 - 1152-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-3042 
<br/><br/><label>Standard No.: </label>10.1046/j.1471-4159.2003.02088.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amyloid beta-Peptides--pharmacology<br/>Apolipoprotein E3<br/>Apolipoprotein E4<br/>Apolipoproteins E--chemistry<br/>Calcium--metabolism<br/>Caspase 3<br/>Caspases--metabolism<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Culture Media, Serum-Free--chemistry<br/>Cytoskeletal Proteins--metabolism<br/>Enzyme Activation--drug effects<br/>Glycogen Synthase Kinase 3--chemistry<br/>Glycogen Synthase Kinase 3 beta<br/>Humans<br/>Neuroblastoma--chemistry<br/>Peptide Fragments--pharmacology<br/>Phosphorylation--drug effects<br/>Protein Isoforms--chemistry<br/>Protein Kinase C--drug effects<br/>Protein Kinase C-alpha<br/>Protein Serine-Threonine Kinases<br/>Protein Transport--drug effects<br/>Proto-Oncogene Proteins--drug effects<br/>Proto-Oncogene Proteins c-akt<br/>Trans-Activators--metabolism<br/>beta Catenin